Tenderwize
Retour à la recherche

Open House Discount Contracts for Ranibizumab (Vial)

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 162 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Ranibizumab, als Durchstechflasche, ATC S01LA04

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

25 / 100

Facteurs de risque

The buyer reserves the right to replace open-house contracts with exclusive contracts from EU tenders, which would auto...

As an open-house model, there is no guaranteed purchase volume or spend; contracts are purely discount agreements.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Mar 31, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Provision of non-exclusive discount contracts for the active substance Ranibizumab (ATC S01LA04) as a vial.
  • Contracts are open to all interested pharmaceutical companies meeting the eligibility criteria.
Afficher le résumé complet

This is an open-house model for non-exclusive discount contracts (Rabattverträge) for the pharmaceutical product Ranibizumab (ATC S01LA04) as a vial, offered by AOK Rheinland-Pfalz/Saarland. The contract period is from 01.06.2025 to 31.05.2027, with the possibility to join at any month start. The first submission deadline for the initial contract start is 30.04.2025. No estimated value is provided. This is not a classic procurement but a voluntary transparency publication.

Risques

The buyer reserves the right to replace open-house contracts with exclusive contracts from EU tenders, which would auto...

As an open-house model, there is no guaranteed purchase volume or spend; contracts are purely discount agreements.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Pharmaceutical company must offer authorized and marketable drugs in Germany.

Administrative

  • Drugs must be listed in the Lauer-Taxe as marketable; otherwise, evidence from AMIce database or other documentation is required.
  • Submission of signed contract documents by specified deadlines.

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open House Discount Contracts for Ranibizumab (Vial)

Non-exclusive discount contracts for Ranibizumab (ATC S01LA04) as a vial. Maximum contract duration 24 months from 01.06.2025 to 31.05.2027. First contract conclusion possible on 01.06.2025. All contracts end at the latest 24 months after the earliest start date. Open to all interested pharmaceutical companies offering authorized and marketable drugs in Germany.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

May 2025 - May 2027

Catégorie

Pharmaceutical products

Date limite

Expired Apr 30, 2025

Détails de la procédure

Date de publication
10 Apr 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
236800-2025

Documents (1)

Appels d'offres similaires